Old Web
English
Sign In
Acemap
>
Paper
>
Revocation of the conditional marketing authorisation of a cancer medicine: The olaratumab experience
Revocation of the conditional marketing authorisation of a cancer medicine: The olaratumab experience
2019
Ralf Herold
Jorge Camarero
Daniela Melchiorri
Zigmars Sebris
Harald Enzmann
Francesco Pignatti
Keywords:
Revocation
Alternative medicine
Cancer Medicine
Medicine
Immunology
Authorization
Drug development
Clinical trial
Olaratumab
Family medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
2
References
4
Citations
NaN
KQI
[]